Published in J Immunother Cancer on October 18, 2016
Epidemiology and risk factors of urothelial bladder cancer. Eur Urol (2012) 4.45
Transplantation--a medical miracle of the 20th century. N Engl J Med (2004) 2.74
Bk virus: a clinical review. Clin Infect Dis (2001) 1.48
BK virus and human cancer: innocent until proven guilty. Semin Cancer Biol (2009) 1.45
Long-term cancer risk of immunosuppressive regimens after kidney transplantation. J Am Soc Nephrol (2010) 1.45
Donor-derived disease transmission events in the United States: data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee. Am J Transplant (2009) 1.20
Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ (2010) 1.18
Oncogenic transformation by BK virus and association with human tumors. Oncogene (2003) 1.16
An update on donor-derived disease transmission in organ transplantation. Am J Transplant (2011) 1.15
Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation (2002) 1.14
Lack of BK virus DNA sequences in most transitional-cell carcinomas of the bladder. Int J Cancer (2007) 0.96
Maintenance versus reduction of immunosuppression in renal transplant recipients with aggressive squamous cell carcinoma. Dermatol Surg (2004) 0.90
Malignancies: pre and post transplantation strategies. Transplant Rev (Orlando) (2013) 0.90
Urothelial carcinoma transmission via kidney transplantation. Nephrol Dial Transplant (2009) 0.81
Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients. Oncotarget (2015) 0.79
Cancers among US organ donors: a comparison of transplant and cancer registry diagnoses. Am J Transplant (2014) 0.78
Revision of immunosuppression in a solid organ transplant recipient leads to complete remission of metastatic undifferentiated carcinoma. JAAD Case Rep (2015) 0.78